WINDLAS BIOTECH
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Windlas Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-2.71₹ -26.05
As on Nov 4, 2025, 4:01 PM IST
Windlas Biotech Price Performance
Today's LowToday's High
₹930.00₹959.50
₹934.50
52 Weeks' Low52 Weeks' High
₹667.30₹1,197.00
₹934.50
Open Price
₹958.00
Prev. Close
₹960.55
Volume
1,246
Over the last 5 years, the share price of Windlas Biotech has gained 18.10% CAGR. Over the past year, the corresponding return has been -9.69%.
Windlas Biotech’s current P/E of 30.05x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Windlas Biotech Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Windlas Biotech | 0.55 | 1.49 | -5.68 | -4.60 | -9.69 | 56.74 | 18.10 |
| Sun Pharmaceutical Industries | 0.33 | 2.35 | 3.15 | -7.76 | -6.42 | 17.65 | 27.40 |
| Divi's Laboratories | 6.12 | 17.18 | 5.13 | 11.31 | 15.80 | 22.16 | 16.40 |
| Cipla | -4.08 | -0.53 | -0.64 | -2.42 | -4.97 | 9.52 | 14.02 |
| Torrent Pharmaceuticals | -0.10 | 1.39 | -1.07 | 8.86 | 11.75 | 28.91 | 22.42 |
| Dr. Reddy's Laboratories | -6.95 | -3.82 | -2.01 | 2.41 | -5.30 | 9.89 | 4.00 |
| Zydus Lifesciences | -2.85 | -2.16 | 1.37 | 9.05 | -3.13 | 30.30 | 17.26 |
| Mankind Pharma | -1.47 | -3.37 | -9.86 | -1.93 | -13.37 | 18.50 | 10.72 |
| Lupin | 4.01 | 3.10 | 6.12 | -4.27 | -8.71 | 41.14 | 16.17 |
| Alkem Laboratories | 4.30 | 3.20 | 15.47 | 11.61 | -2.26 | 20.29 | 16.02 |
| Aurobindo Pharma | 4.77 | 5.10 | 5.60 | -7.30 | -18.14 | 27.67 | 8.06 |
| Abbott India | -1.34 | -2.12 | -13.63 | -4.47 | -0.20 | 14.70 | 13.16 |
| Laurus Labs | 2.36 | 13.77 | 14.00 | 58.86 | 101.49 | 28.34 | 28.79 |
| Glenmark Pharmaceuticals | 1.69 | -6.33 | -10.97 | 31.35 | 8.61 | 63.66 | 29.98 |
| Biocon | 3.92 | 9.50 | -0.58 | 13.22 | 22.27 | 11.53 | -1.52 |
| GlaxoSmithKline Pharmaceuticals | 0.21 | -2.66 | -7.06 | -7.98 | 1.93 | 25.53 | 13.79 |
| Anthem Biosciences | -1.49 | -8.06 | -6.71 | -3.81 | -3.81 | -1.29 | -0.77 |
| Ipca Laboratories | 0.77 | -2.12 | -10.29 | -6.88 | -18.52 | 12.62 | 1.79 |
| Ajanta Pharma | 8.79 | 6.76 | -1.59 | 0.20 | -13.37 | 27.38 | 19.28 |
| Gland Pharma | 0.17 | -1.74 | -3.80 | 34.33 | 18.38 | 1.73 | 0.92 |
Over the last one year, Windlas Biotech has declined 9.69% compared to peers like Sun Pharmaceutical Industries (-6.42%), Divi's Laboratories (15.80%), Cipla (-4.97%). From a 5 year perspective, Windlas Biotech has outperformed peers relative to Sun Pharmaceutical Industries (27.40%) and Divi's Laboratories (16.40%).
Windlas Biotech Financials
Windlas Biotech Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 942.72 | 948.68 |
| 10 | 940.4 | 942.79 |
| 20 | 928.91 | 939.35 |
| 50 | 956.96 | 946.05 |
| 100 | 946.43 | 949.16 |
| 200 | 944.53 | 933.4 |
Windlas Biotech Share Holding Pattern
In the latest quarter, Windlas Biotech saw a drop in promoter holding to 61.99%, while DII stake increased to 11.44%, FII holding fell to 1.11%, and public shareholding moved up to 25.48% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Windlas Biotech Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 8,57,651 | 1.25 | 77.69 | |
| 2,76,027 | 0.3 | 25 | |
| 1,60,507 | 1.33 | 14.54 |
* Excluding Index & Arbitrage Funds
Windlas Biotech Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 29, 2025, 7:08 PM IST | Windlas Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 29, 2025, 6:13 AM IST | Windlas Biotech - Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results For T |
| Oct 08, 2025, 6:19 AM IST | Windlas Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 03, 2025, 11:24 PM IST | Windlas Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 10, 2025, 11:31 PM IST | Windlas Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
About Windlas Biotech
Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company's Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407. Currently Company is involved in the business activities of Manufacture of pulp, paper and paperboard. Company's Total Operating Revenue is Rs. 759.88 Cr. and Equity Capital is Rs. 10.48 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address40/1, Mohabewala Industrial Area, Dehradun Uttarakhand/Uttaranchal 248110
- Contact
Management
- Mr. Vivek DhariwalChairman & Ind.Director
- Mr. Hitesh WindlassManaging Director
- Mr. Manoj Kumar WindlassJoint Managing Director
- Mr. Pawan Kumar SharmaExecutive Director
- Mr. Ashok Kumar WindlassWhole Time Director
- Mrs. Prachi Jain WindlassNon Executive Director
- Mr. Srinivasan VenkataramanIndependent Director
- Mr. Gaurav GulatiIndependent Director
FAQs on Windlas Biotech Share Price
What is the share price of Windlas Biotech?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Windlas Biotech is ₹934.50 as on Nov 04, 2025.
What kind of stock is Windlas Biotech?
The Windlas Biotech is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Windlas Biotech?
The market cap of Windlas Biotech is ₹1,958.65 Cr as on Nov 04, 2025.
What are today's High and Low prices of Windlas Biotech?
Today’s highest and lowest price of Windlas Biotech are ₹959.50 and ₹930.00.
What are the 52 Week High and 52 Week Low of Windlas Biotech?
The 52-week high/low is the highest and lowest price at which Windlas Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Windlas Biotech is ₹1,197.00 and 52-week low of Windlas Biotech is ₹667.30 as on Nov 04, 2025.
How has the Windlas Biotech performed historically in terms of returns?
The Windlas Biotech has shown returns of -2.71% over the past day, 1.49% for the past month, -5.68% over 3 months, -9.69% over 1 year, 56.74% across 3 years, and 18.1% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Windlas Biotech?
P/E ratio of and PB ratio of Windlas Biotech are 30.05 and 4.16 on Nov 04, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse